Research programme: pain therapeutics - Maruho

Drug Profile

Research programme: pain therapeutics - Maruho

Alternative Names: T-type calcium channel/voltage-gated sodium channel blocker - Maruho

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator RaQualia Pharma
  • Developer Maruho
  • Class Analgesics
  • Mechanism of Action Sodium channel antagonists; T type calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Neuropathic pain
  • Research Inflammatory pain

Most Recent Events

  • 30 Dec 2014 RaQualia Pharma receives patent allowance for T-type calcium channel blocker in Japan
  • 23 Jun 2011 Early research in Inflammatory pain in Japan (unspecified route)
  • 23 Jun 2011 Early research in Neuropathic pain in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top